BlackRock, Inc. 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BLACKROCK INC BLK | 4,962,237 8.900% | 193,363 (+4.05%) | Filing |
| 2023-01-25 10:36 am Sale | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BLACKROCK INC BLK | 4,768,874 8.700% | -735,122 (-13.36%) | Filing |
| 2022-03-09 5:18 pm Purchase | 2022-02-28 | 13G | Agios Pharmaceuticals, Inc. AGIO | BLACKROCK INC BLK | 5,503,996 10.100% | 95,460 (+1.76%) | Filing |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BLACKROCK INC BLK | 5,408,536 9.950% | -523,124 (-8.82%) | Filing |
| 2021-08-09 3:23 pm Purchase | 2021-07-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BLACKROCK INC BLK | 5,931,660 10.100% | 1,446,660 (+32.26%) | Filing |
| 2021-01-28 5:55 pm Purchase | 2020-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BLACKROCK INC BLK | 4,485,000 6.500% | 591,606 (+15.20%) | Filing |